Thorium dioxide-related haemangiosarcoma of the liver

Netherlands Journal of Medicine

Volumn 65, Issue 8, 2007, Pages 279-282

  van Kampen, R J W ^a,b   Erdkamp, F L G ^a   Peters, F P J ^a  

^a Zuyderland Medical Centre   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Hepatic haemangiosarcoma; Postradiation cancer; Throrium dioxide

Indexed keywords

ALANINE DEHYDROGENASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; BILIRUBIN; CREATININE; HEMOGLOBIN; THORIUM 232;

ABDOMINAL RADIOGRAPHY; AGED; ANAMNESIS; ANGIOSARCOMA; AUTOPSY; BRAIN ANGIOGRAPHY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CYTOLOGY; DISEASE COURSE; FATALITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TUMOR; MALE; PARACENTESIS; PHYSICAL EXAMINATION; REVIEW;

AGED; CONTRAST MEDIA; HEMANGIOSARCOMA; HUMANS; LIVER NEOPLASMS; MALE; NETHERLANDS; PROGNOSIS; RISK FACTORS; THORIUM DIOXIDE; TIME FACTORS;

EID: 34948818198     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. De Bac C. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: A multicenter Italian study. Hepatology 1994;20:1225.
2. Mani H, van Thiel DH. Mesenchymal tumours of the liver. Clin Liver Disease 2001;5:219-57.
3. MacMahon E, Murphy AS, Bates MI. Endothelial cell sarcoma of the liver following Thorotrast injection. Am J Pathol 1947:585-613.
4. Leitner ZA. Sequelae of Thorotrast. BMJ 1965;2:1062-3.
5. Jansen TL, Meijer JW, Kesseliring FO, Mulder CJ. A surprising double tumour of the liver 60 years following Thorotrast diagnosis. Ned Tijdschr Geneeskd 1992;136:1413-7.
6. Goto A, Takebayashi Y, Liu D, et al. Microdistribution of alpha particles in pathological sections of tissues from Thorotrast patients detected by imaging plate autoradiography. Radiat Res 2002;158:54-60.
7. Sharp GB. The relationship between internally deposited alpha-particle radiation and subsite-specific liver cancer and liver cirrhosis: an analysis of published data. J. Radiat Res 2002:371-80.
8. Harrison JD, Muirhead CR. Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation. Int J Radiat Biol 2003;79:1-13.
9. Ishikawa Y, Wada I, Fukumoto M. Alpha-particle carcinogenesis in Thorotrast patients: epidemiology, dosimetry, pathology and molecular analysis. J Environ Pathol Toxicol Oncol 2001;20:311-5.
10. Nyberg U, Nilsson B, Travis LB, Holm LE, Hall P. Cancer incidence among Swedish patients exposed to radioactive Thorotrast: a forty year follow-up survey. Radiat Res 2002;157:419-25.
11. dos Santos Silva I, Jones ME, Malveiro F, Swerdlow AJ. Mortality in the Portuguese Thorotrast study. Radiat Res 1999;152:S88-92.
12. Dos Santos Silva I, Malveiro F, Jones ME, Swerdlow AJ. Mortality after radiological investigation with radioactive Thorotrast: a follow-up study of up to fifty years in Portugal. Radiat Res 2003;159:521-34.
13. Travis LB, Land CE, Andersson M, et al. Mortality after cerebral angiography with or without radioactive Thorotrast: an international cohort of 3,143 two-year survivors. Radiat Res 2001;156:136-50.
14. Koyama T, Fletcher JG, Johnson CD, Kuo, MS, Notohara K, Burgart L. Primary hepatic angiosarcoma: findings at CT and MR imaging. Radiology 2002;222:667-73.
15. Rademaker J, Widjaja A, Galanski M. Hepatic hemangiosarcoma: imaging findings and differential diagnosis. Eur Radiol. 2000;10:129-33.
16. Blay J-Y, van Glabbeke M, Verweij J, et al. Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy. Eur J Cancer 2003;39:64-9.
17. Weitz J, Klimstra DS, Cymes K, et al. Management of primary liver sarcomas. Cancer 2007;109:1391-6.
18. Lin S-P, Brown JJ. MR contrast agents: physical and pharmacologic basics. J Magn Reson Imaging 2007;25(5):884-99.